Loading clinical trials...
Loading clinical trials...
A Randomized, Placebo-Controlled Trial Comparing the Effects of Commercially Available Dietary Supplements on CoQ10 Concentrations
The primary purpose of this study is to compare the safety and effectiveness of commercially available dietary supplements believed to increase coenzyme Q10 (CoQ10) concentrations. An 8-week, randomized, placebo-controlled clinical trial will be conducted comparing the effectiveness of four commercially available dietary supplements on increasing CoQ10 concentrations and self-reported health outcomes.
Age
40 - No limit years
Sex
ALL
Healthy Volunteers
Yes
True Health Center for Precision Medicine
El Dorado Hills, California, United States
Cornerstone Health Community
Centennial, Colorado, United States
CTMD Research
Palm Springs, Florida, United States
Functional Medicine of Idaho
Eagle, Idaho, United States
New Dawn Wellness and Medical Center
Houston, Texas, United States
Vida Integrated Health
Seattle, Washington, United States
Start Date
October 12, 2024
Primary Completion Date
September 17, 2025
Completion Date
September 17, 2025
Last Updated
March 4, 2026
150
ACTUAL participants
Ubiquinol + geranylgeraniol
DIETARY_SUPPLEMENT
Geranylgeraniol
DIETARY_SUPPLEMENT
Ubiquinol
DIETARY_SUPPLEMENT
Ubiquinone
DIETARY_SUPPLEMENT
Placebo
OTHER
Lead Sponsor
OvationLab
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06716502